People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Healthtech, Biotechnology, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Thyme Care, Inc. | — | Healthtech | Series C | $214.3M | $668.4M | 2021 |
| BigHat Biosciences, Inc. | — | Biotechnology | Series D+ | $148.2M | $2.6B | 2021 |
| Waymark, Inc. / DE | — | Other Technology | Series C | $67.0M | $278.9M | 2021 |
| Pearl Health, Inc. | — | Healthtech | Series C | $55.5M | $721.8M | 2022 |
| Arda Therapeutics, Inc. | — | Biotechnology | Series C | $50.8M | $356.5M | 2024 |
| knownwell, inc. | — | Other Health Care | Series B | $50.1M | $116.2M | 2025 |
| Rezo Therapeutics, Inc. | — | Biotechnology | Series C | $46.3M | $868.3M | 2022 |
| Stipple Bio, Inc. | — | Biotechnology | Series A | $21.5M | $39.7M | 2022 |
Vineeta Agarwala at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Vineeta Agarwala on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Ryan | 1 | 20 |
| Mohamad Makhzoumi | 1 | 10 |
| Tiba Aynechi | 1 | 9 |
| Robert Green | 1 | 8 |
| Simeon George | 1 | 8 |
| Brenton Fargnoli | 1 | 7 |
| Francisco Gimenez | 1 | 7 |
| Jeff DeFlavio | 1 | 5 |
| Ian Chiang | 1 | 5 |
| Vivek Garipalli | 1 | 5 |
| David Whelan | 1 | 5 |
| Scott Kupor | 1 | 5 |
| Owen Hughes | 1 | 4 |
| Puneet Singh | 1 | 4 |
| George Scangos | 1 | 4 |
| Aaron Ring | 1 | 3 |
| Vijay Patel | 1 | 3 |
| Robert Chess | 1 | 3 |
| Theresa Tribble | 1 | 3 |
| Steve Kafka | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.